Status:
COMPLETED
the Effects of Fish Oil Supplements on Choroidal Thickness and Blood Flow Perfusion in Children and Adolescents
Lead Sponsor:
Shanghai Eye Disease Prevention and Treatment Center
Conditions:
Fish Oils
Eligibility:
All Genders
6-9 years
Phase:
PHASE2
Brief Summary
The goal of this clinical trial is to test the effect of fish oil supplement in terms of vision in children and adolescents. The main question it aims to answer is: the differences in changes of chor...
Eligibility Criteria
Inclusion
- Age range: 6-9 years old, gender unspecified;
- Equivalent spherical power after unilateral cycloplegic eye ranging from 0.75D to -0.5D, with astigmatism not exceeding 1.5D;
- Best corrected visual acuity of at least 1.0;
- Ability to sign an informed consent form with the presence and understanding of a parent or guardian.
Exclusion
- Allergy or intolerance to ω-3 PUFAs or cycloplegics;
- Strabismus, history of eye surgery (including strabismus correction surgery), other eye diseases, or systemic diseases;
- Currently using myopia prevention measures.
Key Trial Info
Start Date :
July 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 2 2024
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06877494
Start Date
July 21 2024
End Date
December 2 2024
Last Update
March 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Eye Disease Prevention and Treatment Center
Shanghai, Shanghai Municipality, China, 20041